Imvax

Imvax

Imvax

Imvax, a biotech company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Founded
2015
Raised
$112M
Follow us
Latest funding
$112,000,000
Venture capital (Series C) - 2020
Invus Magnetar Capital Ziff Capital Partners +2
Team Size
1–10
Employees
$112,000,000 Venture capital (Series C)
FinSMEs

Imvax Raises $112M in Series C Financing